Recombinant Human EFEMP2 Protein, Glycoengineered Human Cell Line (CAT#: GLJF-0922-JF369)

Product Overview	Recombinant Human EFEMP2 protein (NP_058634.4) is produced in Glycoengineered Human Cell Line. This expression system is used for the production of glycoproteins and antibodies with human post-translational modifications.
Source	Glycoengineered Human Cell Lines
Species	Human
Tag	His-Tag, FC-Tag or other Tags as required.
Purity	>90%
Endotoxin Level	Regular batch
Conjugation	None

Target	EFEMP2
Full Name	EGF-containing fibulin-like extracellular matrix protein 2
Gene ID	30008
Uniprot ID	O95967
Accession Number	NP_058634.4
Background	A large number of extracellular matrix proteins have been found to contain variations of the epidermal growth factor (EGF) domain and have been implicated in functions as diverse as blood coagulation, activation of complement and determination of cell fate during development. The protein encoded by this gene contains four EGF2 domains and six calcium-binding EGF2 domains.
Alternate Names	MBP1; UPH1; FBLN4; ARCL1B